In this paper the interaction of genetic and nutritional variables in the homocysteine (Hcy) metabolic pathway genes and its cofactors have been reviewed to assess their influence on general health. Hcy metabolism leads to the synthesis of 2 amino acids-methionine that gives rise to S-Adenosyl-methionine (SAM), the main methyl donor to cellular biomolecules, and cysteine. Hyperhomocysteinemia (hypHcy) is a potential risk condition for various disorders like Neural Tube Defects (NTD), Congenital Heart Disease (CHD). It is shown how mutations in certain Hcy-pathway genes, especially MTHFR C677T, become a risk for NTD and CHD and other diseases in one population but not in the other, exemplifying the importance of gene-nutrition interaction in disease manifestation. Deficiency of micronutrients folates and vitamin B12, which are important constituents of the Hcy-pathway, can independently act as strong risk factors for the same diseases. A survey in the eastern part of India records that almost 50% population is deficient in vitamin B12, 11% in folates, and nearly 30% is hyperhomocysteinemic, indicating high disease predisposition. Globally the highest incidence of undernutrition and low birth weight occurs in this region. A high proportion of individuals afflicted with cleft lip±palate, male infertility, recurrent pregnancy failures and the chromosomal disorder, Down syndrome, have MTHFR 677T homozygosity as a risk factor but the extent of risk is modulated depending upon the levels of vitamin B12, folates and Hcy. Thus the genetic disease burden is influenced by the level of micronutrients. It is recommended that supplementation of both folates and vitamin B12 should be considered for prospective mothers during pregnancy.
Introduction
Despite a reasonably good economic progress, India continues to have a high incidence of undernutrition and low birth weight. Health indices in the eastern region of India which includes eastern U.P., Bihar and Jharkhand, are even poorer than the rest of India (James, 2011). There is ample evidence to conclude that the children afflicted with mal-or undernourishment neonatally, run greater risk of suffering from cognitive and other organic impairment in later life (see Ames, 2006) . This article proposes to elucidate how nutrition influences genetic constitution of an individual in determining its phenotype, particularly in the manifestation of disease, and finally suggest that intake of adequate amounts of micronutrients could ensure proper maternal health, good pregnancy outcome and enduring child health even in cases of genetic susceptibility. Based on our own research work in the eastern regions of India, this paper focuses on the Homocysteine-1-Carbon metabolic pathway that is vital for diverse biological functions to demonstrate how Hcy levels could vary due to modulation of gene function by micronutrients.
greater than 15µmol/l is considered moderately high (hyper-homocysteinemia; hypHcy) while its level in excess of 60µmol/l is potentially a disease condition, homocysteinuria (see Sullivan et al., 2015) . Though not a disease by itself, individuals having hypHcy show susceptibility to various disorders. As illustrated in Fig.  1 , conversion of Hcy into methionine requires addition of a methyl group (1-carbon) culled from 5-Methyltetrahydrofolate (M-THF) and catalysed by the enzymes MTR (methionine synthase) and MTRR (methionine synthase reductase). While addition of -CH 3 to Hcy converts it to Met, CH 3 -THF after losing the methyl group is converted to tetrahyrdrofolate (THF). CH 3 -THF is a reduced form of 5,10 methylenetetrahydrofolate, catalysed by the enzyme Methylene-tetrahydrofolate reductase (MTHFR). Sulfonation of Hcy leading to the formation of Cysteine, has an intervening step of cystathionine formation prior to conversion to Cys, the enzyme involved being cystathionine beta synthase (CBS). The catalytic reactions required for conversion of Hcy in either direction need vitamins as cofactors; vitamin B12 for the 1-C and vitamin B6 for the trans-sulphuration pathways. In addition, supply of folate as substrate for the Hcy-Met reaction is vital. This paper covers some of the reasons for hypHcy and its predisposition to multifactorial effects as well as Down syndromea chromosomal disorder.
Folates and Vitamin B12 and Gene Polymorphisms as Disease Risk Factors -a Glimpse into History
The importance of Hcy-pathway related micronutrients in disease management came into light in the decade of 1920s, when George Minot, an American haematologist, tried "weird" nutritional regimes-raw liver, half-cooked hamburgers, raw hog stomach, even regurgitated gastric juices -as dietary treatment for pernicious anaemia. In 1926 he along with Dr William Murphy concluded that the cause of this anaemia was dearth of an important nutrient present in liver extract-a finding that fetched them Nobel Prize in 1934 (Murphy, 1934 . There was another kind of anaemia, detected particularly in pregnant mothers in India that was as "pernicious" as the other one but non-responsive to Minot's recipes. Lucy Wills, a British physician, travelled to India in 1928, and found its cure by feeding marmite (extracted et al., 2014) . Understanding of their clinical significance in several other diseases soon followed.
One of the most striking revelations of the human genome sequencing is that despite being more than 99% identical, human genomes differ from each other in hundreds of thousands of nucleotides. Individually, most of these variations are phenotypically innocuous. Therefore they survive in the population undetected, and are called polymorphisms (majority of them Single Nucleotide Polymorphism, SNP) rather than mutations. However, combinations of SNPs and other changes affect the phenotype under certain environmental conditions, highlighting the inevitability of the gene-gene and gene-environment interaction in the development of phenotypes, particularly the disease phenotype. The disorders caused due to interaction of one or more than one gene with the environment are collectively defined as the Multifactorial disorders (MD). One of the most obvious environmental factors that influence health and disease conditions is nutrition.
Hyperhomocysteinemia, Folate Deficiency, Hcy Pathway Enzymes as Risk Factors for Neural Tube Defects (NTD) and Congenital Heart Disease (CHD) NTD and CHD are among the most common developmental disorders. In case of the former, children are born with incompletely closed neural tube. In population-specific manner its incidence ranges from 1 in 500 to 1 in 1000 live-births. Smithells et al. (1976) were among the first to show that mothers of the NTD children were deficient in several vitamins, more importantly folates. This observation led them to offer women periconceptionally with a dose of multivitamins having 0.36mg folic acid (Smithells et al., 1981) . This was one of the first clear evidence of association of micronutrients with a developmental disorder. Literature is now replete with papers supporting this piece of observation (see Heseker, 2011) . CHD is a group of congenital heart ailments manifesting at birth or later in life. Studies from different parts of the world have shown maternal hypHcy and folate deficiency as important risk factors for CHD (see Huhta et al., 2005) . In response to this overwhelming body of evidence, governments in North America and Europe, have fortified flour and other grain products with folates, making it an integral part of diet. Population surveys in U.S.A., Canada and Europe after more than 10 years of introduction of folate supplementation have shown a striking drop in frequency of NTD (especially spina bifida) and CHDs (MRC 1991; CDC 2009; Zinck et al., 2015) . It should be noted, however, that the decline in the frequency is only up to 20%. Therefore, analysis of genetic proclivity of individuals to specific disease is intuitively a good possibility.
Study on the genetic susceptibility of multifactorial disorders has been greatly facilitated by the vast repertoire of DNA polymorphisms recorded from human genomes. One of the simpler approaches is the "case-control" study in which frequency of certain polymorphisms of gene in a cohort of randomly collected disease individuals is compared with that of a group of unaffected, matched (control) individuals from the same geographic location. Statistically significant difference in frequency of the normal (major) and mutant (minor) alleles between the diseased and control samples suggests association of the allele with the disease. Similar approach was adopted in the case of NTD and CHD in which polymorphisms in the genes for enzymes in the Hcy-pathway were compared in the case-control format. One of the genes chosen for this study was for the enzyme Methylene tetrahydrofolate reductase (MTHFR) which catalyses conversion of 5,10 methylene THF to 5methylTHF, the substrate contributing -CH 3 group to Hcy for the synthesis of methionine. A transition from Cytosine to Thymine at position 677(exon 4) of cDNA (MTHFR C677T) leading to replacement of valine with alanine lowers the enzyme activity by 35% in heterozygous (CT) and by 70% in homozygous TT condition (Frost et al., 1995) (Fig. 2) . Several studies from different parts of the world, have shown its association with several diseases including NTD, CHD and also with hypHcy. However, the results are not consistent with most of the diseases. While in certain reports 677TT homozygotes show strong association with the disease, in others no association is detected. In fact, a survey of the frequency of this SNP in normal populations from different parts of the world shows significant difference in the incidence of TT, ranging from >30% in Mexicans and North Americans to 2-3% in Asians (Indian subcontinent) and <1% in Africans (McAndrew et al., 1996; Stevenson et al., 1997; Schneider et al., 1998 , Mutchinik et al., 1999 (Table 1) . Clearly if 30% of the 677TT individuals in a population are normal, unaffected by a disease, TT homozygous would be an unlikely candidate as a risk allele. On the other hand, less than 3% of this genotype in parts of Asia and Africa indicates a low selective value of this mutant in this region. It turns out that T allele (CT/TT) leads to elevation of Hcy level which also correlates with the level of folates and vitamin B12 (Refsum, 2001) . In American and European populations where non vegetarian diet and flour fortification maintain good vitamin B12 and folate levels, the Hcy level remains in check even in the presence of MTHFR 677TT genotype. In contrast, in populations poor in folate and/or vitamin B12 levels, TT homozygosity is a serious risk factor that elevates Hcy levels, leading to hypHCy (Sukla and Raman, 2012) . Thus the selective potential of this variant is dependent on the nutritional profile of the population, and therefore genetic contribution to the manifestation of the disease phenotype is modulated by the intake of micronutrients. Another MTHFR SNP, A1298C that occurs downstream of C677T has also been detected as a risk factor for several disorders. More importantly compound heterozygotes of both the variants prove to be a greater risk than an individual variant. Other genes of the Hcy-pathway (MTR, MTRR, RFC1, CBS etc.) have been tested as risk factors for NTD and CHD and other diseases (Table  2) , each of them showing an association in some populations but not in others. Generally this association is population specific and shows a broad correlation with the diet of the individuals in that population.
Gene-Micronutrient Interaction in Hyperhomocysteinemia (An Indian Study)
Lakshmi et al. (2001) and Refsum et al. (2001) working in the Southern and Western regions of India were among the first to show that in these populations Hcy level was generally higher; and folate and vitamin (Sharma et al., 1994; Kumar et al., 2009; Godbole et al., 2011) .
In the light of the sporadic studies showing that the frequency of MTHFR 677T was rather low in India compared with those of European, North American and Japanese populations, we carried out a systematic population-based study on the Hcypathway gene polymorphism, status of vitamin B12 and folate and their impact, individually and interactively, on Hcy level (Sukla and Raman, 2012; Sukla et al., 2013) . The results and their import are summarised below.
The study was conducted on blood samples of 1426 (820 males and 606 females) "normal" and "healthy" adult individuals from different regions of Varanasi in eastern Uttar Pradesh (n=387), western Bihar (n=214), Jharkhand (n=561) and Chhattisgarh (n=264) to make an appraisal of their contribution to hypHcy and disease susceptibility. More than 36% individuals were vegetarians, and most others were occasional non-vegetarians. Keeping WHO values as standard, nearly 30% of the population was hypHcy (>15µmol/l; optimum range 3-12 µmol/l), 11% was folate deficient (optimum range 3-24ng/ml plasma) and 50% was deficient in vitamin B12 (optimum range 220-1200pg/ml plasma). While average Hcy level was higher in males than in females, frequency of hypHcy was also greater in males as well as in vegetarians. Vitamin B12 deficiency, on the other hand, was independent of gender but strongly correlated with vegetarians which was true for other regional populations also. What was intriguing was that the frequency of individuals with vitamin B12 deficiency was much greater than those with folate deficiency, possibly because Vitamin B12 is primarily derived through animal foods, and Indians largely depend on vegetarian foods. That folates played smaller role in Hcy level was confirmed by the fact that among those having only folate deficiency and Vitamin B12 being optimum, 22% were hypHcy while in those having only Vitamin B12 deficiency 41% suffered from hypHcy. Of course in the individuals where both nutrients were optimum or deficient the frequency of hypHcy was 11% and 63%, respectively. Clearly, the Hcy level varied under the influence of both folate and Vitamin B12, impact of the latter being more severe.
When hypHcy level was viewed in the genomic context, polymorphisms in CBS and MTR did not influence Hcy levels. In contrast, both the mutant alleles of MTHFR 677T and 1298C, showed strong association with Hcy level, the median being 20.8µmol/ l in 677TT and 13.1µmol/l in1298CC individuals. The minor allele of RFC1 (now called SLC19A1) 80A, on the other hand, proved to be protective against hypHcy. The group homozygous for RFC180AA had Hcy value of 9.9, lowest among all the groups.
We now present evidence of how nutrition 
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Raman and Narayan (1995) and later Tamara et al (2003) demonstrated that inhibition of DNA methylation in mouse spermatogonia inhibited their transition into primary spermatocytes, suggesting important role of DNA methylation in spermatogenesis. Hypomethylation of the DMR2 (differential methylation Region) of Igf2 has been shown to cause infertility in rat (Murphy et al., 2011) . Therefore when association of MTHFR C677T and A1298C in cases of idiopathic male infertility in an Indian cohort was studied, it showed extremely low frequency of T allele in MTHFRC667T (9% in control and 17% in the cases), especially TT homozygosity (4% in cases and 0.0% in controls) but also that T allele was a risk factor in male infertility, more so in the homozygous condition (Singh et al., 2005) . A metaanalysis on results from different parts of the world overwhelmingly shows the T allele to be a risk factor in male infertility, especially in homozygous condition (Liu et al., 2015) . Majority of the studies (more than 10) from different regions of India, considered in the meta-analysis, demonstrate MTHFR 677T allele to be a risk factor for infertility. The meta-analysis showed no association of A1298C from MTHFR, with infertility though the report from eastern India did indicate association albeit much less than with 677T (Singh et al., 2010) . There are no studies on other Hcy-pathway genes from India. Global data find MTRR as a mild risk factor for male infertility (see Liu et al., 2015) . Ebisch et al. (2006a, b) , whose earlier study from Europe did not find an association of MTHFR 677T with infertility (Ebisch et al., 2003) , found both folate deficiency and Hcy elevation as risk factors for male infertility, and recommended folate supplementation as a therapy.
There is no clear report on Hcy-pathway genes as risk factor in female infertility. However, in a casecontrol study, association of MTHFR677T and 1298C with recurrent pregnancy failure has been documented (Nair et al., 2012 (Nair et al., , 2013 in cases drawn from eastern India. There are several other studies from different parts of the world which corroborate the role of MTHFR variants and early pregnancy failures (see Cao et al., 2013) . Through a detailed study on early development, Enciso et al. (2016) have demonstrated strong association of MTHFR variants (677T and 1298C) on failure of blastocyst implantation and chromosomal aneuploidy as cause of early and recurrent pregnancy failures. They observed that while 25% of embryos having failed implantation were homozygous for 677T, only about 5% (1 out of 19 embryos) with successful pregnancy had 677TT homozygosity. Thus the role of MTHFR variants as risk factors for poor pregnancy outcome seems well established, and periconceptional supplementation of folates for mitigation has been internationally practiced. In India whether folate alone or in combination with vitamin B12 is a better alternative needs to be tested.
Nonsyndromic Cleft lip±Palate
Clefting of lip or palate is one of the most common congenital disorders, globally. The majority of cases occur sporadically but nearly 10-15% cases show a familial trend suggesting a genetic predisposition, which in interaction with the prevailing environmental condition, may result in the disorder. It being a congenital disease, quite naturally maternal environment during gestation period, parental genotype as well as the gestational environment and genetic constitution of the affected foetus, all could contribute to the development of the NSCL±P. Association of the Hcy pathway genes and Hcy level and folates has been analysed in cases and/or case-mothers from different parts of the world. In this case too, the results are quite mixed: with respect to MTHFR 677TT homozygosity, genotypes of either the mother or the probands or both or none of them was associated with NSCL±P (Ali et al., 2009; see Sullivan et al., 2015) . In our case-control study, conducted on more than 500 subjects (cases 323, controls 214), TT homozygosity was associated as risk factor both for the case as well as case-mothers (Ali et al., 2009) . MTHFR A1298C did not show an association. In RFC1 G80A, the gene involved in cellular folate absorption, the G allele was also a risk allele and 677TT/GG80 together were a greater risk than any of them individually, but, as stated earlier, RFC1 80A proved to be protective against NSCL±P even in the presence of 677TT homozygosity (Kumari et al., 2013) . However, a recent study on a relatively smaller sample size in southern India (Murthy et al., 2014) does not show the association with either of the risk SNPs. It finds, on the other hand, that in RFC1, the minor allele A, is associated with the disease (Lakkakula et al., 2015) .
An intriguing feature of NSCL±P is that its frequency is much higher in males than in females, the general ratio is 2:1, and this pattern is seen globally. While assaying Hcy level in the case-children in a case-control format, we found Hcy level to be elevated in cases than in controls, and the incidence of hypHcy was strikingly higher in the cases. The most revealing observation was that the level of Hcy was greater in the female case-children than in the males. This was striking because in general population (control) the level of Hcy is significantly higher in males than in females, while in NSCL±P, the levels were the opposite. It is also to be noted that nearly 60% of affected female children showed hypHcy even if they carried 677CC genotype which is not a risk genotype. Most likely these children suffered from Vitamin B12 and/or folate deficiency during pregnancy. This leads us to surmise that a higher level of Hcy threshold is necessary for expression of NSCL±P in females than in males, and that could be one of the reasons for lower incidence of the disease in females (Kumari et al., 2013) .
Low Birth Weight (LBW) and Neonatal Hyperbilirubinemia (NNH)
The frequency of neonatal deaths and low birth weight (LBW) are the highest in India, and one of the obvious reasons for it is the poor maternal health during pregnancy that affects foetal growth. More than 35% children born are clinically LBW (body weight <2.5kg), and they are generally born to undernourished mothers many of whom are also deficient in folic acid and vitamin B12 and consequently high Hcy (Yajnik et al., 2005) . Taneja et al. (2007) also reported deficiency of these micronutrients in children within an age group of 6 to 30months from northern India. We carried out a study on the cord blood of more than 400 just-born children in the University hospital to assay their Vitamin B12, folate and Hcy levels along with the genotype of the Hcy-pathway genes. Sixteen percent of the children were prematurely born while 38% showed LBW, and a subgroup of 25% children suffered from NNH. Surprisingly, their nutritional parameters were even poorer than those of adults from the same region: 25% children were hypHcy, and Vitamin B12 and folate deficiency was seen respectively in 65% and 27% children. This is the poorest statement on neonatal health, world-wide. All the three nutritional parameters individually are putative risk factors for LBW. This scenario is exacerbated by the fact that MTHFR 677T and RFC1 A80G are the genomic risk factors for this trait. Within this cohort, 25% children developed jaundice (NNH) within 72h of birth. MTHFR 677T and folate deficiency proved to be clear risk factors for this transient malady (Sukla et al., 2013) . These independent studies conducted in different parts of India allude to the fact that extreme paucity of micronutrients and their genetic predisposition may lead to diverse neonatal disorders, leading to high child mortality and even later age effect on their health. There is evidence that children having Vitamin B12 deficiency during foetal and neonatal stage run a high risk of coronary artery disease and neurological disorders, more specifically cognitive impairment (Huxley 2006).
Down Syndrome (DS)
On an average one out of 700 new-borns is afflicted with Down syndrome, a disorder leading to intellectual disability and multiple organ malfunctions. DS is a chromosomal disorder caused due to trisomy of chromosome 21 arising from error in chromosome distribution during parental meiosis. More than 85% occur due to nondisjunction in maternal meiosis (see Hassold and Hunt, 2001) . The only risk factor associated with DS is the age of the mother, particularly mothers older than 35 years at the time of conception (Penrose, 1933) . Efforts to identify genetic risk factors were not successful until James et al. (1999) and Hobbs et al. (2000) showed in two independent case-control studies from America that MTHFR 677T is strongly associated with casemothers. Over 60 studies have so far been conducted on association of Hcy-pathway genes with DS in different parts of the world, including Indian subcontinent. The broad pattern is that, MTHFR-DS association is more pronounced in Asian than in the European populations. In Europe, for instance, majority of the studies show no association of MTHFR/Hcy with DS, excepting 5 reports from Italy in which association of various Hcy pathway genes was apparent (for review, see Rai V et al., 2014; Coppede et al., 2015) . In Europe, the consensus of opinion is that the lack of association is due to adequate micronutrient supplementation both through folates in the flour and Vitamin B12 through non-vegetarian diet. However, numerous independent genotype, studies from across the world have shown that nutritional deficiency and high Hcy level are uniformly risk factors for DS in case mothers (see Sukla et al., 2015) .
In India the first systematic study on association of DS with MTHFR 677T showed MTHFR 677T to be a risk factor for DS (Rai A. et al., 2006) . More importantly, 677TT homozygosity was seen predominantly in younger case mothers (<30 years) implying that those young mothers may be genetically predisposed to have DS children (Rai A. et al., 2006) . Since then, a number of studies from different regions of India have been published, and while some of them do show this polymorphism as a risk factor (Rai A et al., 2006; Cyril et al., 2009; Pandey et al., 2013 , Sukla et al., 2015 , there are others that do not find any association (Kohli et al., 2008; Mohanty et al., 2012; Kaur and Kaur, 2013) . Jaiswal et al. (2015) working in the eastern region of India showed that SNPs -579G>T and -149C>T in a DNA methyl-transferase gene, DNMT3b, does not show any association with DS. Such discrepancies point to the role of other Hcypathway genes as well as the role of Hcy-pathway micronutrients in this chromosomal disorder.
In a rather detailed, integrated triad study, Sukla et al. (2015) have analysed genotypes of 7 variants in 6 Hcy pathway genes as well as levels of micronutrients and Hcy in DS children as well as their parents. The study, conducted on 151 case-triads and 200 controls each for male, female and the young, confirmed the role of MTHFR 677T as risk factor in mother, father and DS children. In RFC1 G80A, the A allele turns out to be protective but only in DS children, both in homo-as well as heterozygous condition. The other variants viz., MTR A2756G, MTHFR A1298C, MTRR A66G, CBS 844 ins84bp and TCN2 C776G do not show significant association. However, when the variant combinations were genotyped, 56% of DS mothers had 4 or more variants (out of the 7 analysed) as against 10% control mothers. Among the DS and control children the difference was even more staggering (65% in DS vs 13% in controls) while among fathers there was no difference. This result is comparable to some of the studies from Italy, Spain and Brazil (da Silva et al., 2005; Coppede et al., 2006; Biselli et al., 2008) . By implication, other variants also contribute to the risk of DS in small measures, and the paternal genotype (except MTHFR 677T) does not seem to have a bearing on the risk. Sukla et al. (2015) also showed that Vitamin B12 and folate levels are uniformly much lower in the case group (case mother, father and DS) than the controls. Hcy level was higher in both the parents but lower in the DS children. In fact DS children had the lowest Hcy among all the different groups. This lowering is explained by the strikingly high level of cysteine in the DS (see Sukla et al., 2015) . Since CBS gene, that catalyses Hcy in the sulfonation pathway, is present on chromosome 21, its 3 copies must drive Hcy towards cysteine synthesis, the pathway that leads to loss of Hcy. Thus elevated level of cysteine and lowered level of Hcy are expected in DS children which could also be a survival advantage for them. More importantly, as earlier shown for LBW cases, the combination of MTHFR 677T and Vitamin B12 and/or folate deficiency and elevated Hcy is a far greater risk in DS mothers.
Accumulation of Hcy is a manifestation of lowered synthesis of methionine, which in turn lowers SAM level that would globally affect methylation of target sites, causing hypomethylation of a number of sites and their expression pattern. There are also reports that the pericentromeric heterochromatin is highly methylated. Both James et al. (1999) and Hobbs et al. (2000) had conjectured that hypomethylation of the centromeric region would create inadequate condensation of the centromeric region causing malsegregation of chromosomes. There is sufficient evidence showing that nutritional deficiency of the vitamins, exacerbated by the genetic constitution, creates a condition for chromosomal aneuploidy (Hollis et al., 2013; Encise et al., 2016) .
In this rather personalised review, I have presented evidence to establish the role of Hcypathway genes in the development of several disorders at all levels: congenital, late age or even chromosomal. It is also shown that the possible adverse effect of the genic variants could substantially be modified by the nutritional environment of the individual. The matter of particular concern is that it is reflective of the poor maternal health during pregnancy, and that a better management during those months could reduce disease burden to a large extent. In India, supplementation of iron, and also folic acid, to prospective mothers during pregnancy since last 40 years, has not brought down the incidence of anaemia in any significant way. There is a need to rethink on the supplementation regime, both in terms of their timing, content and implementation. The limited scope that our work provides leads us to advocate for (i) the need for planned pregnancy and use of the supplementation months before its start, (ii) assessing the folate levels individually before deciding its dose and (iii) inclusion of Vitamin B12 in the recipe as an essential ingredient. Minor changes in nutritional course could make a big change in the health scenario of the population. 
